NDC 83703-535-16 - IFOSFAMIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83703-535
- Requested NDC
- 83703-535-16
- Package NDCs from labels
- 83703-535-16, 83703-535-02
- Manufacturer
- Bamboo US Biidco LCC
- Effective date
- 2024-06-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| IFOSFAMIDE - Bamboo US Biidco LCC | Bamboo US Biidco LCC | 2024-06-20 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ifosfamide | IFOSFAMIDE FOR INJECTION | SteriMax Inc. | 98798c5e-8384-4990-a1b5-60dfb1e667bb | 2026-09-01 | UM20QQM95Y | |
| Ifosfamide | IFOSFAMIDE | Fresenius Kabi USA, LLC | a311a947-7b78-4226-bfe0-f4aa0be20e27 | 2026-04-09 | Boxed warning, Warnings, Adverse reactions | UM20QQM95Y |
| IFEX | IFOSFAMIDE | Baxter Healthcare Corporation | b7241707-7538-4d1a-91e7-3a25a91e0b9a | 2024-12-02 | Boxed warning, Warnings, Adverse reactions | UM20QQM95Y |
| IFOSFAMIDE | IFOSFAMIDE | Baxter Healthcare Company | 91e433a9-6800-43a6-ac13-a49a04a5aecd | 2024-12-02 | Boxed warning, Warnings, Adverse reactions | UM20QQM95Y |
| IFOSFAMIDE | IFOSFAMIDE | Baxter Healthcare Company | efb1d03b-2d91-406e-8110-d3a58b8fa7cc | 2024-12-02 | Boxed warning, Warnings, Adverse reactions | UM20QQM95Y |
| 1b529055-473e-d5a5-e063-6394a90a47ca | 1b52a2e3-cd61-a8a4-e063-6394a90a00b7 | 2024-06-20 | Boxed warning, Warnings, Adverse reactions | 1b529055-473e-d5a5-e063-6394a90a47ca 1b52a2e3-cd61-a8a4-e063-6394a90a00b7 | ||
| Ifosfamide | IFOSFAMIDE | Hikma Pharmaceuticals USA Inc. | c90ab05f-8fe5-437e-a1c0-8b11ef63291e | 2020-06-01 | Boxed warning, Warnings, Adverse reactions | UM20QQM95Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.